- Home
- PGEN vs GNL Comparison
PGEN vs GNL Comparison
Compare PGEN & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | GNL |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PGEN | GNL |
|---|---|---|
| Price | $4.20 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.67 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 5.0M | 1.7M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.94% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,309,000.00 | ★ $751,333,000.00 |
| Revenue This Year | $342.78 | N/A |
| Revenue Next Year | $478.46 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 59.20 | 17.63 |
| 52 Week Low | $0.76 | $6.51 |
| 52 Week High | $5.23 | $8.62 |
Technical Indicators
Market Signals| Indicator | PGEN | GNL |
|---|---|---|
| Relative Strength Index (RSI) | 54.86 | 64.02 |
| Support Level | $4.05 | $8.20 |
| Resistance Level | $4.53 | $8.62 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 69.99 | 96.51 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.